İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

ERCAN OĞUZ

ÖĞRETİM GÖREVLİSİ (DERS VERMEKLE GÖREVLİ)

IĞDIR ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ

  • Ana Dal Mühendislik Temel Alanı
  • Yan Dal Biyomühendislik

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 25
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 1 Q2 19 Q3 1 Q4 4
WoS (JCR) Q1 1 Q2 14 Q3 6 Q4 4
TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 6
Ort. yüzdelik 81.2%
Üst %1 payı 0.0%
Üst %10 payı 25.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 25 yayın

TR Index
0 makale

Makale listesi

  1. 2026 Synthesis and in Silico Evaluation of Novel Triazolone‐Derived Naphthalene‐2‐Sulfonates, Evaluation of Potential Antiproliferative Agents and Enzyme Inhibitory Activities Biotechnology and Applied Biochemistry DOI 10.1002/bab.70140 YÖKSİS SJR Q2 JCR Q3 OpenAlex 86.9%
  2. 2026 Novel 1-morpholine-3-substituted triazol-5-ones: Synthesis and multi-biological evaluation on HepG2 and U87 cells with SAR and DFT studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.143622 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.4%
  3. 2026 Dual Inhibition of AChE and GST by 1,2,4‐Triazine‐3‐Amine: Integrated Biochemical, Computational, and Hepatotoxicity Insights Biotechnology and Applied Biochemistry DOI 10.1002/bab.70098 YÖKSİS SJR Q2 JCR Q3 OpenAlex 89.0%
  4. 2026 3‐Substituted Triazolone–Benzoate Hybrids: Synthesis, Enzyme Inhibition, Anticancer Activity and ADMET Evaluation by Molecular Docking and Dynamics Studies Drug Development Research DOI 10.1002/ddr.70222 YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.3%
  5. 2026 Synthesis of Piperazine‐Linked Sulfonamide Derivatives and Their Inhibitory Effects on Glutathione S‐Transferase: In Vitro and In Silico Approach Biotechnology and Applied Biochemistry DOI 10.1002/bab.70172 YÖKSİS SJR Q2 JCR Q3 OpenAlex 27.6%
  6. 2026 Integrated network pharmacology and in vitro/in silico evaluation of the bioactive potential of Gundelia komagenensis fırat extracts Cytotechnology DOI 10.1007/s10616-026-01053-0 YÖKSİS SJR Q3 JCR Q3 OpenAlex 81.9%
  7. 2026 Multitarget Enzyme Inhibition and Anticancer Potential of 3‐Substituted Indole Derivatives Supported by Molecular Docking Studies Biotechnology and Applied Biochemistry DOI 10.1002/bab.70166 YÖKSİS SJR Q2 JCR Q3 OpenAlex 26.9%
  8. 2025 Synthesis of 4-diazocyclohexane-based sulfonamide drug scaffolds: Investigating enzyme inhibition, antioxidant, and ADMET properties Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.141708 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  9. 2025 New methyl/benzyl‐1,2,4‐triazole‐3‐one Derivatives: Synthesis, Characterization (IR, NMR), Antidiabetic, Anti‐Alzheimer, and Molecular Docking Study Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.70510 YÖKSİS SJR Q2 JCR Q2 OpenAlex 85.5%
  10. 2025 Synthesis and characterization of novel bis(thiosemicarbazone) complexes and investigation of their acetylcholinesterase and glutathione S-transferase activities with in silico and in vitro studies Molecular Diversity DOI 10.1007/s11030-024-10895-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.1%
  11. 2025 Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.70591 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.8%
  12. 2025 Synthesis, characterization of novel mannich bases and their acetylcholinesterase and glutathione S-transferase inhibitory properties: An in vitro and in silico mechanism research Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.139733 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.2%
  13. 2025 The Cytotoxic Effect on HepG2 Cell Line and In Vitro, In Silico Evaluation of 1,2,4‐Triazine Compounds as Inhibitors of Acetylcholinesterase and Glutathione S‐Transferase Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.70415 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  14. 2024 Synthesis and examination of 1,2,4‐triazine‐sulfonamide hybrids as potential inhibitory drugs: Inhibition effects on AChE and GST enzymes in silico and in vitro conditions Archiv der Pharmazie DOI 10.1002/ardp.202400182 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 97.4%
  15. 2024 Pharmacological assessment of disulfide–triazine hybrids: synthesis, enzyme inhibition, and molecular docking study Medicinal Chemistry Research DOI 10.1007/s00044-024-03251-x YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 97.2%
  16. 2024 1,2,4-Triazol 4-Bromobenzenesulfonates: Synthesis, Characterization (IR, NMR), DFT, Enzym Activities, and Docking Study Russian Journal of Physical Chemistry A DOI 10.1134/S0036024424040204 YÖKSİS SJR Q4 JCR Q4 OpenAlex 82.0%
  17. 2023 Analysis of bioactive compounds using LC\u2010ESI\u2010MS/MS, cytotoxic, antimicrobial effects and enzyme activities from\n Cyclotrichium origanifolium Chemical Biology Drug Design DOI 10.1111/cbdd.14177 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.2%
  18. 2023 Novel Mannich bases derived from 1,2,4-triazoles: Design, synthesis, characterization, and glutathione S-transferase inhibition properties investigations Elsevier BV DOI 10.1016/j.molstruc.2023.136321 YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.9%
  19. 2022 In Silico and In Vitro Analysis of Acetylcholinesterase and Glutathione S-transferase Enzymes of Substituted Pyrazoles Russian Journal of General Chemistry DOI 10.1134/S1070363222110263 YÖKSİS SJR Q4 JCR Q4 OpenAlex 76.2%
  20. 2026 Novel 1-morpholine-3-substituted triazol-5-ones: Synthesis and multi-biological evaluation on HepG2 and U87 cells with SAR and DFT studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.143622 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.4%

Akademisyenlere dön